Brca2 deficiency and Trp53 deregulation in pancreatic cancer: Implications for therapeutic targeting

Abstract

Commentary to:

Inactivation of Brca2 cooperates with Trp53^R172H to induce invasive pancreatic ductal adenocarcinomas in mice: A mouse model of familial pancreatic cancer

Georg Feldmann, Collins Karikari, Marco dal Molin, Stephanie Duringer, Petra Volkmann, Detlef K. Bartsch, Savita Bisht, Jan-Bart Koorstra, Peter Brossart, Anirban Maitra and Volker Fendrich

This article refers to:

Inactivation of Brca2 cooperates with Trp53R172H to induce invasive pancreatic ductal adenocarcinomas in mice